NCT03472742View on ClinicalTrials.gov

An Follow-Up Study of Liver Cirrhosis

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

October 12, 2023

Study Completion Date

October 12, 2023

Conditions
Decompensated Liver Cirrhosis
Interventions
DRUG

Mesenchymal Stem Cell

As this is a follow-up and an observation study, ADR-001 was administered in the previous study, not in this study.

Trial Locations (1)

951-8510

Niigata University Medical & Dental Hospital, Niigata

All Listed Sponsors
lead

Rohto Pharmaceutical Co., Ltd.

INDUSTRY

NCT03472742 - An Follow-Up Study of Liver Cirrhosis | Biotech Hunter | Biotech Hunter